Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 7
2003 9
2004 13
2005 11
2006 15
2007 10
2008 12
2009 9
2010 16
2011 9
2012 11
2013 13
2014 18
2015 19
2016 15
2017 12
2018 15
2019 14
2020 18
2021 12
2022 13
2023 4
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Results by year

Filters applied: . Clear all
Page 1
Towards a European prospective data registry for particle therapy.
Grau C, Dasu A, Troost EGC, Haustermans K, Weber DC, Langendijk JA, Gregoire V, Orlandi E, Thariat J, Journy N, Chaikh A, Isambert A, Alicja Jereczek-Fossa B, Vaniqui A, Vitek P, Kopec R, Fijten R, Luetgendorf-Caucig C, Olko P. Grau C, et al. Among authors: gregoire v. Radiother Oncol. 2024 Apr 21;196:110293. doi: 10.1016/j.radonc.2024.110293. Online ahead of print. Radiother Oncol. 2024. PMID: 38653379
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL; KEYNOTE-412 Investigators. Machiels JP, et al. Among authors: gregoire v. Lancet Oncol. 2024 Mar 29:S1470-2045(24)00100-1. doi: 10.1016/S1470-2045(24)00100-1. Online ahead of print. Lancet Oncol. 2024. PMID: 38561010
Deep-learning for rapid estimation of the out-of-field dose in external beam photon radiotherapy - A proof of concept.
Benzazon N, Carré A, de Kermenguy F, Niyoteka S, Maury P, Colnot J, M'hamdi M, Aichi ME, Veres C, Allodji R, Vathaire F, Sarrut D, Journy N, Alapetite C, Grégoire V, Deutsch E, Diallo I, Robert C. Benzazon N, et al. Among authors: gregoire v. Int J Radiat Oncol Biol Phys. 2024 Mar 28:S0360-3016(24)00423-1. doi: 10.1016/j.ijrobp.2024.03.007. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38554830
Low-frequency somatic mutations are heritable in tropical trees Dicorynia guianensis and Sextonia rubra.
Schmitt S, Heuret P, Troispoux V, Beraud M, Cazal J, Chancerel É, Cravero C, Guichoux E, Lepais O, Loureiro J, Marande W, Martin-Ducup O, Vincent G, Chave J, Plomion C, Leroy T, Heuertz M, Tysklind N. Schmitt S, et al. Among authors: vincent g. Proc Natl Acad Sci U S A. 2024 Mar 5;121(10):e2313312121. doi: 10.1073/pnas.2313312121. Epub 2024 Feb 27. Proc Natl Acad Sci U S A. 2024. PMID: 38412128
Long-term health-related quality of life in head and neck cancer survivors: A large multinational study.
Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto A, Hammerlid E, Scricciolo M, Jansen F, Verdonck-de Leeuw IM, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC, Stromberger C, Specenier P, Tramacere F, Bushnak A, Perotti P, Plath M, Paderno A, Stempler N, Kouri M, Grégoire V, Singer S; EORTC Quality of Life Group and the EORTC Head and Neck Group. Taylor KJ, et al. Among authors: gregoire v. Int J Cancer. 2024 May 15;154(10):1772-1785. doi: 10.1002/ijc.34861. Epub 2024 Feb 5. Int J Cancer. 2024. PMID: 38312044
Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer.
Mortensen HR, Populaire P, Hoffmann L, Moeller DS, Appelt A, Nafteux P, Muijs CT, Grau C, Hawkins MA, Troost EGC, Defraene G, Canters R, Clarke CS, Weber DC, Korevaar EW, Haustermans K, Nordsmark M, Gebski V, Achiam MP, Markar SR, Radhakrishna G, Berbee M, Scartoni D, Orlandi E, Doyen J, Gregoire V, Crehange G, Langendijk J, Lorgelly P, Blommenstein HM, Byskov CS, Ehmsen ML, Jensen MF, Freixas GV, Bütof R; PROTECT consortium. Mortensen HR, et al. Among authors: gregoire v. Radiother Oncol. 2024 Jan;190:109980. doi: 10.1016/j.radonc.2023.109980. Epub 2023 Nov 5. Radiother Oncol. 2024. PMID: 37935284 No abstract available.
Salivary gland cancers in elderly patients: challenges and therapeutic strategies.
Colombo E, Van Lierde C, Zlate A, Jensen A, Gatta G, Didonè F, Licitra LF, Grégoire V, Vander Poorten V, Locati LD. Colombo E, et al. Among authors: gregoire v. Front Oncol. 2022 Nov 25;12:1032471. doi: 10.3389/fonc.2022.1032471. eCollection 2022. Front Oncol. 2022. PMID: 36505842 Free PMC article. Review.
248 results